| STAGE OF DEVELOPMENT | |||||
|---|---|---|---|---|---|
| Program | Approach | Indication | Discovery | Lead Optimization | IND Enabling |
| PLA-GBM™ (Internal) | Platelet-mediated delivery of siRNA/miRNA | Glioblastoma |  | 2023 | |
| PLA-ONCO™ (Out-Licensing)* or (For Partnering)* | Platelet-mediated delivery of siRNA | Solid Tumors |  | 2024 | |
CURRENT PIPELINE
(*) Plasfer is actively looking for partners to move this program forward